Ditemukan 39693 dokumen yang sesuai dengan query :: Simpan CSV
Influenza is one of the ARI diseases that receives attention because it can cause outbreaks. In Indonesia, influenza positivity rate reached 40.3%, where the identified viruses are virus A (subtype H1N1Pdm09 and AH3) and virus B (subtype Victoria). The purpose of this study is to determine the factors that influence the incidence of Influenza A and B in DKI Jakarta in 2021-2022. Cross sectional study and cox regression analysis estimating the Prevalence Ratio (PR) value were conducted by utilizing secondary data of Influenza Like Illness surveillance in DKI Jakarta in 2021-2022. The results showed that the prevalence of positive Influenza was 27.8%. The results of multivariate analysis showed that the risk factors associated with influenza A and B were age>5-64 years had a PR of 0.51 times (p-value = 0.006; 95% CI = 0.31 - 0.82), contact with sick people had a PR of 2.27 times (p-value = <0.001; 95% CI = 1.45 - 3.56), and the rainy season had a PR of 3.26 times (p-value = <0.001; 95% CI = 1.68 - 6.33) of influenza A and B infection. The rainy season is the dominant factor influencing the incidence of influenza A and B in DKI Jakarta in 2021-2022.
Provinsi DKI Jakarta merupakan salah satu dari 4 Provinsi di Indonesia yang menjadi tempat implementasi awal dari penerapan penggunaan paduan BPaL (Bedaquiline, Pretomanid, Linezolid) untuk pengobatan TB RO dalam tatanan penelitian operasional. Tujuan penelitian ini adalah membandingkan keberhasilan pengobatan pasien TB RO pada penggunaan Bedaquiline dalam paduan pengobatan dengan keberhasilan pengobatan pasien TB RO tanpa Bedaquiline dalam paduan pengobatan. Penelitian menggunakan rancangan kohort retrospektif dan analisis datanya dengan analisis survival dari data Sistem Informasi Tuberkulosis (SITB) Provinsi DKI Jakarta tahun 2020 – 2023. Hasil penelitian: Pada pola resistansi Monoresistan, Rifampisin Resistan, Poliresistan dan Multidrugs Resistant keberhasilan paduan pengobatan yang menggunakan Bedaquiline tidak menunjukkan perbedaan yang bermakna dengan keberhasilan pengobatan menggunakan paduan tanpa Bedaquiline setelah dikontrol oleh variabel jenis paduan pengobatan (HR 1,01; 95% CI 0,79 -1,29; p-value= 0,939). Pada pola resistansi pre-Extensively Drug Resistant dan Extensively Drug Resistant, keberhasilan paduan pengobatan menggunakan Bedaquiline juga tidak berbeda bermakna bila dibandingkan keberhasilan paduan pengobatan tanpa Bedaquiline dengan mempertimbangkan jenis paduan pengobatan (HR 1,14; 95% CI 0,34 – 3,82; p-value= 0,835). Diharapkan tenaga kesehatan tetap memberikan edukasi pentingnya kepatuhan regimen pengobatan dan dukungan sosial serta psikologis kepada pasien untuk menbantu pasien tetap konsisten menjalani pengobatan.
DKI Jakarta Province is one of 4 Provinces in Indonesia for the initial implementation site of the BPaL (Bedaquiline, Pretomanid, Linezolid) combination for treating DR-TB (Drug Resistant Tuberculosis) in an operational research order. The study aimed to compare the success of treatment of TB RO patients with the use of Bedaquiline in the treatment combination with the success of treatment of TB RO patients without Bedaquiline in the treatment combination. The study used a retrospective cohort design and data analysis with survival analysis from the Tuberculosis Information System (SITB) data of DKI Jakarta Province in 2020 – 2023. Results of the study shows that in Monoresistant, Rifampicin Resistant, Polyresistant and Multidrugs Resistant resistance patterns, the success of treatment combination using Bedaquiline did not show a significant difference with the success of treatment combination without using Bedaquiline after being controlled by treatment combination type variable (HR 1.01; 95% CI 0.79 -1.29; p-value = 0.939). In pre-Extensively Drug Resistant and Extensively Drug Resistant resistance patterns, the success of treatment combination using Bedaquiline was also not significantly different when compared to the success of the treatment combination without Bedaquiline after being controlled by treatment combination type variable (HR 1.14; 95% CI 0.34 – 3.82; p-value = 0.835). Health workers are expected to continue providing education on the importance of compliance with treatment regimens and giving social and psychological support to patients in order to maintain patient’s consistency in undergoing treatment.
Increased incidence of drug-resistant tuberculosis (DRTB) is a major public health problem in Indonesia. One of risk factors for the emergence of DRTB case is a high prevalence of type-2 diabetes mellitus (DM). The prevalence of type-2 DM in patients with DRTB is very high, ranging from 18.8% to 23.3%. This study aimed to determine relationship between type-2 DM and the incidence of DRTB in Malay community, Riau Province, in 2014-2018. The quantitative study design was case control in 251 cases (DRTB) and 502 controls (drug-sensitive tuberculosis / DSTB). Quantitative data were obtained from DRTB secondary data, namely Form 01.DRTB, Form 03.DRTB, medical records and electronic TB manager (e-TB manager); while, DSTB secondary data were obtained from DSTB Form.01, DSTB Form.03, medical records and Integrated Tuberculosis Information System. The independent variable was type-2 DM, and the covariate variables were age, sex, education, occupation, residence category, marital status, HIV status and previous TB treatment record. In supporting the quantitative study, qualitative study was conducted with life history approach using a small group discussion method and in-depth interview. Quantitative data were analysed with logistic regression. Quantitative study results showed that peoples with type-2 DM had a 2.27 times risk (95% CI: 1.58-3.27) to experience the incidence of DRTB if compared to peoples without type-2 DM after controlling for occupation, residence, marital status and previous TB treatment record. The results of qualitative study were to obtain a record of the incidence of type-2 DM that occurred earlier than the incidence of DRTB and to examine socio-cultural risk factors affecting the occurrence of DRTB in the Malay community, Riau Province. Possible socio-cultural risk factors associated with DRTB were habits of drinking sweet drinks, adherence to taking DRTB medicine, adherence to taking DM medicine, and the community of Mainland Malay
